RecruitingPhase 3NCT06430125
Nephroprotective Effect of Nicorandil in Type 2 Diabetes Mellitus
Clinical Study Evaluating the Nephroprotective Effect of Nicorandil in Patients With Type 2 Diabetes Mellitus
Sponsor
Tanta University
Enrollment
46 participants
Start Date
Feb 28, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
This study aims to evaluate the possible nephroprotective effect of nicorandil in patients with type 2 diabetes mellitus .
Eligibility
Min Age: 18 YearsMax Age: 60 Years
Plain Language Summary
Simplified for easier understanding
This study is testing whether nicorandil — a drug normally used to treat chest pain (angina) by opening blood vessels — can protect the kidneys in people with early-stage chronic kidney disease (CKD) who also have Type 2 diabetes. Researchers want to see if the drug slows kidney decline.
**You may be eligible if...**
- You have been newly diagnosed with Type 2 diabetes that is well-controlled with diet alone (HbA1c below 7)
- You are between 18 and 60 years old
- You have Stage 1 or Stage 2 chronic kidney disease according to standard guidelines
- Your blood pressure is controlled
**You may NOT be eligible if...**
- You are pregnant or breastfeeding
- You are allergic to nicorandil
- Your kidney disease is caused by uncontrolled blood pressure, kidney cancer, a connective tissue disorder (like lupus), or a disease like amyloidosis or rheumatic fever
- You are taking blood pressure medications such as ACE inhibitors or ARBs, or other specific antihypertensive drugs
- You are taking medications that are toxic to the kidneys (such as aminoglycosides, NSAIDs, or contrast dyes)
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGNicorandil 10 MG Oral Tablet
Nicorandil 10 MG oral tablet twice daily
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06430125
Related Trials
SnapDandCGMinType2Diabetes
NCT075336041 location
Clinical Study to Assess the Safety, Efficacy and In-Use Tolerability of Herbal-Based Sugar Support Effervescent Tablets in Type-2 Diabetes Mellitus Patients
NCT069610191 location
Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD
NCT064498331 location